Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (1 active)

Company-led only

6 records in Main database · 3 strong · 5 status checked

Compare	Program	Company / Sponsor	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications
Add	SENS-401 (Arazasetron) by Sensorion	Sensorion	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedStrong evidence	company · Priority 1	94%	AdultSudden / SSNHL+2	Hearing LossSensorineural Hearing Loss+2
Add	AC102 by AudioCure Pharma	AudioCure Pharma	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedStrong evidence	trial · Priority 1	91%	AdultSudden / SSNHL+1	Hearing LossSensorineural Hearing Loss+2
Add	NS101 by Neuracle Science	Neuracle Science Co., Ltd.	Therapeutic	-	Biologic	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	92%	AdultSudden / SSNHL+2	Hearing LossSensorineural Hearing Loss+2
Add	FX-322 by Frequency Therapeutics	Frequency Therapeutics	Therapeutic	-	Regenerative Medicine	Phase 2	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 1	96%	Adult	Hearing LossSensorineural Hearing Loss+2
Add	AM-111 by Auris Medical and Altamira	Altamira Therapeutics	Therapeutic	-	Biologic	Phase 3	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	95%	AdultSudden / SSNHL+1	Hearing LossSensorineural Hearing Loss+1
Add	Strekin STR001 for Sudden Sensorineural Hearing Loss	Strekin AG	Therapeutic	-	Small Molecule	Phase 3	Completed	Details checkedClinical trial listing onlyHistorical/discontinued	registry · Priority 2	82%	AdultSudden / SSNHL+2	Hearing LossSudden Sensorineural Hearing Loss+1